Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical magnesium sulfate spray for prevention of sore throat after double-lumen tube intubation
IRCT20211011052724N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of magnesium sulfate in pharyngitis and dysphonia (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Reduction in postoperative sore throat and Reduction in postoperative hoarseness. Started Jan 2026; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
pharyngitisdysphonia
Beyond the preview
Go deeper on IRCT20211011052724N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211011052724N1.